Healthcare -
Biotechnology - NASDAQ - US
$ 9.94
7.81 %
$ 220 M
Market Cap
-4.56
P/E
INMB - TOTAL LIABILITIES
Total Liabilities INMB - INmune Bio, Inc.
18.9 M
LAST VALUE
-2.20%
2 YEAR CAGR
87.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR